About Toledo Clinic Cancer Centers-Monroe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
72
Alliance for Clinical Trials in Oncology
20
Clinical Trials at Toledo Clinic Cancer Centers-Monroe
During the past decade, Toledo Clinic Cancer Centers-Monroe conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 58 clinical trials were completed, i.e. on
average, 113.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 23 clinical trials were completed. i.e. 135.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2008-04-01
2015-07-01
Terminated
12
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Monroe" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials
sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "GOG Foundation"
with 10 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Monroe"
#1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Toledo Clinic Cancer Centers-Monroe
According to Clinical.Site data, the most researched conditions in "Toledo Clinic Cancer Centers-Monroe" are
"Recurrent Breast Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials), "Clear Cell Renal Cell Carcinoma" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Toledo Clinic Cancer Centers-Monroe" in a lesser frequency.
Clinical Trials Intervention Types at Toledo Clinic Cancer Centers-Monroe
Most popular intervention types in "Toledo Clinic Cancer Centers-Monroe" are "Drug" (106 trials), "Other" (86 trials), "Biological" (64 trials), "Procedure" (26 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (37 trials), "Bevacizumab" (16 trials), "Computed Tomography" (16 trials) and "Biospecimen Collection" (15 trials). Other intervention names were less common.
Clinical Trials Genders at Toledo Clinic Cancer Centers-Monroe
The vast majority of trials in "Toledo Clinic Cancer Centers-Monroe" are
104 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Toledo Clinic Cancer Centers-Monroe
Currently, there are NaN active trials in "Toledo Clinic Cancer Centers-Monroe".
undefined are not yet recruiting,
31 are recruiting,
54 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 26 completed trials in Toledo Clinic Cancer Centers-Monroe,
1 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Toledo Clinic Cancer Centers-Monroe, 6 "Phase 1"
clinical trials were conducted, 58 "Phase 2" clinical
trials and 63 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".